Related Experiment Video

Updated: Jun 2, 2026

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells
09:24

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells

Published on: August 12, 2015

Characterization of BCAR4, a novel oncogene causing endocrine resistance in human breast cancer cells

Marcia Godinho1, Danielle Meijer, Buddy Setyono-Han

  • 1Department of Pathology, Josephine Nefkens Institute, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.

Journal of Cellular Physiology
|April 21, 2011
PubMed

Insights

Breast cancer antiestrogen resistance 4 (BCAR4) drives tamoxifen resistance and estrogen-independent growth. Its restricted expression suggests BCAR4 is a potential therapeutic target for resistant breast cancers.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Tamoxifen resistance is a significant challenge in estrogen receptor-positive breast cancer management.
  • Understanding resistance mechanisms is crucial for developing improved therapies.
  • Breast cancer antiestrogen resistance 4 (BCAR4) was identified as a gene involved in tamoxifen resistance.

Purpose of the Study:

  • To investigate the role of BCAR4 in endocrine resistance.
  • To evaluate BCAR4's potential as a therapeutic target.

Main Methods:

  • Forced expression of BCAR4 in human breast cancer cell lines (ZR-75-1, MCF7).
  • Inhibition of estrogen receptor 1 (ESR1) using small interfering RNA (siRNA).
  • Assessment of BCAR4 homologues' function in tamoxifen-resistant cell proliferation.
  • Tumorigenicity assay by injecting BCAR4-expressing cells into nude mice.
  • In silico analysis of BCAR4 mRNA expression in normal human tissues.

Main Results:

  • Forced BCAR4 expression promoted estrogen-independent proliferation and resistance to antiestrogens.
  • BCAR4-induced resistance mechanism is independent of ESR1.
  • BCAR4 homologues from primates induced tamoxifen-resistant proliferation.
  • BCAR4-expressing cells formed rapidly growing tumors in vivo.
  • BCAR4 mRNA is highly expressed in human placenta and oocyte, but absent in other normal tissues.

Conclusions:

  • BCAR4 acts as a potent transforming gene, inducing estrogen-independent growth and antiestrogen resistance.
  • BCAR4 promotes tumor formation in vivo.
  • BCAR4's restricted expression pattern makes it a promising therapeutic target for antiestrogen-resistant breast cancer.

More Related Videos

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA108:53

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1

Published on: February 17, 2011

Initiation of Metastatic Breast Carcinoma by Targeting of the Ductal Epithelium with Adenovirus-Cre: A Novel Transgenic Mouse Model of Breast Cancer07:13

Initiation of Metastatic Breast Carcinoma by Targeting of the Ductal Epithelium with Adenovirus-Cre: A Novel Transgenic Mouse Model of Breast Cancer

Published on: March 26, 2014

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...